

Spinal Cord Stimulation Restores Neural Function in SMA Patients
A groundbreaking clinical trial has demonstrated that spinal cord stimulation can help restore motor function in patients with spinal muscle atrophy (SMA), a severe neurodegenerative disease. Researchers at the University of Pittsburgh found that this drug-free, minimally invasive therapy improves muscle strength, walking ability, and fatigue levels, offering a new hope for treating neurodegenerative conditions.
Spinal Cord Stimulation: A New Approach to SMA Treatment
SMA is a genetic disorder that causes progressive loss of motor neurons, leading to severe muscle weakness and movement impairments. Current treatments, including gene therapy and medications, focus on slowing disease progression but do not reverse damage to nerve cells.
In this new study, researchers used spinalcord electrical stimulation to reactivate silent motor neurons, essentially rewiring neural connections to improve mobility and muscle function.
“To counteract neurodegeneration, we need two things—stop neuron death and restore function of surviving neurons,” said Dr. Marco Capogrosso, study co-author.
Clinical Trial Results: A Life-Changing Breakthrough
Three SMA patients participated in a 29-day pilot trial, undergoing spinalcord stimulation five times a week. The results were remarkable:
✔ All participants showed improved motor function
✔ Increased walking endurance by at least 20 meters
✔ Reduced fatigue and improved daily activity performance
✔ Improved motoneuron electrical function and strength
“Patients don’t expect to get better over time—but that’s exactly what we saw,” said Dr. Elvira Pirondini.
This therapy offers a potential alternative for other neurodegenerative diseases, including ALS and Huntington’s disease, by stimulating damaged neural pathways to restore movement.
Future Prospects: Expanding the Treatment
With encouraging early results, researchers plan to launch larger clinical trials to determine the long-term effectiveness of this approach. If successful, spinal cord stimulation could redefine treatment strategies for neurodegenerative diseases, providing millions of patients with renewed mobility and hope.
More Information: First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy, Nature Medicine (2025). DOI: 10.1038/s41591-024-03484-8.
more recommended stories
Machine Learning Predicts Early Mortality in IBD Patients
A groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated Guidelines
A recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early Osteoarthritis
A recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?
The rising obesity epidemic has fueled.
Toxic Soil and Water Linked to Global Heart Disease Crisis
A groundbreaking review published in Atherosclerosis.
Women’s Health: 195 New Genetic Risks Revealed
In a groundbreaking study published in.
Cytomegalovirus Transmission – New Study Uncovers Key to Prevention
A groundbreaking study co-authored by Weill.
Top 10 Spring CME/CE Conferences in USA – 2025
Staying up to date with the.
Semen Quality as a Predictor of Long-Term Health
A landmark study published in Human.
Leave a Comment